108 related articles for article (PubMed ID: 21092535)
1. [Clinical characteristics of hepatic veno-occlusive disease in 6 children with hematologic neoplasm treated with 6-thioguanine].
Wang HS; Gao YJ; Li J; Lu FJ; Miao H; Qian XW; Zhu XF
Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):708-10. PubMed ID: 21092535
[TBL] [Abstract][Full Text] [Related]
2. Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942).
Jacobs SS; Stork LC; Bostrom BC; Hutchinson R; Holcenberg J; Reaman GH; Erdmann G; Franklin J; Neglia JP; Steinberg SM; Balis FM; Adamson PC; ;
Pediatr Blood Cancer; 2007 Sep; 49(3):250-5. PubMed ID: 16856155
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with danhong injection for hepatic veno-occlusive disease.
Yao JY; Zhi M; Cao WT; Huang Y; Li CJ
Hepatogastroenterology; 2011; 58(107-108):992-5. PubMed ID: 21830430
[TBL] [Abstract][Full Text] [Related]
4. Association of hepatic veno-occlusive disease with interstitial pneumonitis in bone marrow transplant recipients.
Wingard JR; Mellits ED; Jones RJ; Beschorner WE; Sostrin MB; Burns WH; Santos GW; Saral R
Bone Marrow Transplant; 1989 Nov; 4(6):685-9. PubMed ID: 2819287
[TBL] [Abstract][Full Text] [Related]
5. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
Lennard L; Richards S; Cartwright CS; Mitchell C; Lilleyman JS; Vora A;
Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of low-dose heparin and prostaglandin E1 in the prevention of hepatic veno-occlusive disease after allogenic hematopoietic stem cell transplantation in children with beta-thalassemia major].
Sun X; Hao WG; Liu S; Xia T; Liao C
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):343-6. PubMed ID: 17706036
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease.
Zhuge YZ; Wang Y; Zhang F; Zhu CK; Zhang W; Zhang M; He Q; Yang J; He J; Chen J; Zou XP
Liver Int; 2018 Oct; 38(10):1867-1874. PubMed ID: 29297975
[TBL] [Abstract][Full Text] [Related]
8. Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.
Lee JH; Lee KH; Choi JS; Zang DY; Kim SB; Kim SW; Suh C; Lee JS; Kim WK; Lee YS; Kim SH
J Korean Med Sci; 1996 Apr; 11(2):118-26. PubMed ID: 8835758
[TBL] [Abstract][Full Text] [Related]
9. Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: effectiveness and a scoring system for initiating treatment.
Bajwa RP; Cant AJ; Abinun M; Flood TJ; Hodges S; Hale JP; Skinner R
Bone Marrow Transplant; 2003 Apr; 31(7):591-7. PubMed ID: 12692627
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen.
Cacchione A; LeMaitre A; Couanet DV; Benhamou E; Amoroso L; Simonnard N; Hartmann O
Bone Marrow Transplant; 2008 Oct; 42(7):449-54. PubMed ID: 18587430
[TBL] [Abstract][Full Text] [Related]
11. Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia.
Stoneham S; Lennard L; Coen P; Lilleyman J; Saha V
Br J Haematol; 2003 Oct; 123(1):100-2. PubMed ID: 14510948
[TBL] [Abstract][Full Text] [Related]
12. Hepatic veno-occlusive disease in children undergoing bone-marrow transplantation: usefulness of sonographic findings.
McCarville MB; Hoffer FA; Howard SC; Goloubeva O; Kauffman WM
Pediatr Radiol; 2001 Feb; 31(2):102-5. PubMed ID: 11214676
[TBL] [Abstract][Full Text] [Related]
13. Veno-occlusive disease in a male patient with Marfan syndrome and common acute lymphoblastic leukemia during induction therapy.
Kraemer DM; Waschke J; Kunzmann V; Wilhelm M
Ann Hematol; 2003 Jul; 82(7):444-7. PubMed ID: 12761649
[TBL] [Abstract][Full Text] [Related]
14. Hepatic veno-occlusive disease related to tacrolimus after pancreas transplantation.
Wang SE; Shyr YM; Lee RC
J Chin Med Assoc; 2013 Jun; 76(6):358-60. PubMed ID: 23602212
[TBL] [Abstract][Full Text] [Related]
15. Defibrotide for the treatment of hepatic veno-occlusive disease in children.
Bulley SR; Strahm B; Doyle J; Dupuis LL
Pediatr Blood Cancer; 2007 Jun; 48(7):700-4. PubMed ID: 16786586
[TBL] [Abstract][Full Text] [Related]
16. Early-onset hepatic veno-occlusive disease after liver transplantation: an institutional experience and analysis of a literature-based cohort.
Endo Y; Shinoda M; Maehara J; Hibi T; Hasegawa Y; Obara H; Kitago M; Ojima H; Tanabe M; Kitagawa Y
Surg Today; 2024 Jul; 54(7):670-682. PubMed ID: 38055106
[TBL] [Abstract][Full Text] [Related]
17. Veno-occlusive disease in pediatric patients affected by Wilms tumor.
Cesaro S; Spiller M; Sartori MT; Alaggio R; Peruzzo M; Saggiorato G; Bisogno G
Pediatr Blood Cancer; 2011 Aug; 57(2):258-61. PubMed ID: 21246705
[TBL] [Abstract][Full Text] [Related]
18. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
19. Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy.
Broxson EH; Dole M; Wong R; Laya BF; Stork L
Pediatr Blood Cancer; 2005 Mar; 44(3):226-31. PubMed ID: 15503293
[TBL] [Abstract][Full Text] [Related]
20. Ocular hemorrhage secondary to thioguanine-associated veno-occlusive disease in a child with acute lymphoblastic leukemia in delayed intensification.
Bhunia N; Yeager ND; Colace SI; Buzzaco D; Bajwa RPS
Pediatr Transplant; 2020 Feb; 24(1):e13638. PubMed ID: 31840375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
